Literature DB >> 21785830

The effect of down regulation of calcineurin Aα by lentiviral vector-mediated RNAi on the biological behavior of small-cell lung cancer and its bone metastasis.

Ning-Qiang Ma1, Li-Li Liu, Jie Min, Jun-Wei Wang, Wei-Feng Jiang, Yan Liu, Yan-Guo Feng, Hai-Chuan Su, Ying-Ming Feng, He-Long Zhang.   

Abstract

Bone is the third most common site of cancer metastasis. Over 30 to 40% of lung cancers can develop skeletal metastasis and no effective curative therapy exists in clinic cases. Previously we screened the different expression of proteins between SBC-5 cells and SBC-3 cells by proteomic study methods (MALDI-TOF/TOF-MS) and found that calcineurin (hereafter referred as Cn) overexpresses in SBC-5 which has special priority in metastasis to bone in a multiple-organ metastasis mice model. However the roles of Cn in osteotropism of SCLC remain to be elucidated. At present study, we decrease CnAα expression in SBC-5 by lentiviral vector-mediated RNAi and found that down regulation of CnAα gene expression can decrease the proliferation and colony formation rate, impede the cell cycle progression, reduce the cell migration and invasion, and inhibit cells adhering to bone matrix, but not change the apoptosis rate of SBC-5 in vitro. In vivo down or up regulation of CnAα gene expression can only decrease or increase the bone metastasis rate, but not affect the metastasis rate to the visceral organs. Our research reveals that CnAα is closely related to the osteotropism metastasis of SCLC and a candidate tumor promotor gene for developing bone metastases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21785830     DOI: 10.1007/s10585-011-9408-6

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  40 in total

Review 1.  Molecular biology of bone metastasis.

Authors:  Lauren A Kingsley; Pierrick G J Fournier; John M Chirgwin; Theresa A Guise
Journal:  Mol Cancer Ther       Date:  2007-10       Impact factor: 6.261

2.  Bone metastasis model with multiorgan dissemination of human small-cell lung cancer (SBC-5) cells in natural killer cell-depleted SCID mice.

Authors:  T Miki; S Yano; M Hanibuchi; S Sone
Journal:  Oncol Res       Date:  2000       Impact factor: 5.574

Review 3.  Mechanisms of cancer metastasis to the bone.

Authors:  Juan Juan Yin; Claire B Pollock; Kathleen Kelly
Journal:  Cell Res       Date:  2005-01       Impact factor: 25.617

4.  Tumor necrosis factor enhances parathyroid hormone-related protein-induced hypercalcemia and bone resorption without inhibiting bone formation in vivo.

Authors:  H L Uy; G R Mundy; B F Boyce; B M Story; C R Dunstan; J J Yin; G D Roodman; T A Guise
Journal:  Cancer Res       Date:  1997-08-01       Impact factor: 12.701

5.  An experimental model of bone metastasis by human lung cancer cells: the role of parathyroid hormone-related protein in bone metastasis.

Authors:  H Iguchi; S Tanaka; Y Ozawa; T Kashiwakuma; T Kimura; T Hiraga; H Ozawa; A Kono
Journal:  Cancer Res       Date:  1996-09-01       Impact factor: 12.701

6.  Expression and function of the nuclear factor of activated T cells in colon carcinoma cells: involvement in the regulation of cyclooxygenase-2.

Authors:  Javier Duque; Manuel Fresno; Miguel A Iñiguez
Journal:  J Biol Chem       Date:  2005-01-04       Impact factor: 5.157

7.  A general method for gene knockdown in mice by using lentiviral vectors expressing small interfering RNA.

Authors:  Gustavo Tiscornia; Oded Singer; Masahito Ikawa; Inder M Verma
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-27       Impact factor: 11.205

8.  Cyclosporine A inhibits colorectal cancer proliferation probably by regulating expression levels of c-Myc, p21(WAF1/CIP1) and proliferating cell nuclear antigen.

Authors:  Takashige Masuo; Shinichi Okamura; Yajing Zhang; Masatomo Mori
Journal:  Cancer Lett       Date:  2009-05-28       Impact factor: 8.679

9.  Follistatin suppresses the production of experimental multiple-organ metastasis by small cell lung cancer cells in natural killer cell-depleted SCID mice.

Authors:  Hirokazu Ogino; Seiji Yano; Soji Kakiuchi; Hiroaki Muguruma; Kenji Ikuta; Masaki Hanibuchi; Hisanori Uehara; Kunihiro Tsuchida; Hiromu Sugino; Saburo Sone
Journal:  Clin Cancer Res       Date:  2008-02-01       Impact factor: 12.531

10.  Cyclosporin A promotes growth and invasiveness in vitro of human first-trimester trophoblast cells via MAPK3/MAPK1-mediated AP1 and Ca2+/calcineurin/NFAT signaling pathways.

Authors:  Mei-Rong Du; Wen-Hui Zhou; Lin Dong; Xiao-Yong Zhu; Yin-Yan He; Jin-Ying Yang; Da-Jin Li
Journal:  Biol Reprod       Date:  2008-03-05       Impact factor: 4.285

View more
  5 in total

1.  Primary mucinous adenocarcinoma of the lung: A case report and review of the literature.

Authors:  Yan Liu; He-Long Zhang; Jia-Zhuan Mei; Yan-Wei Guo; Rui-Jun Li; Si-Dong Wei; Fu Tian; Lu Yang; Hui Wang
Journal:  Oncol Lett       Date:  2017-07-20       Impact factor: 2.967

Review 2.  Calcineurin in development and disease.

Authors:  Lei Chen; Min Song; Chunyan Yao
Journal:  Genes Dis       Date:  2021-03-15

Review 3.  The Role of Calmodulin in Tumor Cell Migration, Invasiveness, and Metastasis.

Authors:  Antonio Villalobo; Martin W Berchtold
Journal:  Int J Mol Sci       Date:  2020-01-24       Impact factor: 5.923

Review 4.  Roles of calcium signaling in cancer metastasis to bone.

Authors:  Tianying Xie; Sitong Chen; Jiang Hao; Pengfei Wu; Xuelian Gu; Haifeng Wei; Zhenxi Li; Jianru Xiao
Journal:  Explor Target Antitumor Ther       Date:  2022-08-31

5.  Overexpression of C16orf74 is involved in aggressive pancreatic cancers.

Authors:  Toru Nakamura; Toyomasa Katagiri; Shoki Sato; Toshihiro Kushibiki; Koji Hontani; Takahiro Tsuchikawa; Satoshi Hirano; Yusuke Nakamura
Journal:  Oncotarget       Date:  2016-07-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.